| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 307.82B | 304.74B | 276.81B | 260.50B | 237.38B | 202.67B |
| Gross Profit | 140.09B | 137.07B | 122.69B | 111.80B | 99.18B | 79.87B |
| EBITDA | 39.01B | 36.98B | 29.24B | 24.79B | 20.61B | 13.84B |
| Net Income | 16.18B | 13.32B | 10.05B | 5.03B | 6.42B | 3.48B |
Balance Sheet | ||||||
| Total Assets | 367.24B | 369.24B | 376.26B | 355.92B | 327.53B | 319.67B |
| Cash, Cash Equivalents and Short-Term Investments | 37.96B | 39.43B | 32.68B | 36.32B | 30.74B | 32.61B |
| Total Debt | 110.68B | 118.25B | 127.13B | 138.21B | 120.73B | 130.49B |
| Total Liabilities | 209.39B | 211.22B | 224.92B | 224.16B | 205.90B | 206.58B |
| Stockholders Equity | 155.64B | 155.97B | 149.10B | 129.79B | 120.07B | 111.69B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 22.25B | 21.70B | -2.92B | 11.56B | -14.86B |
| Operating Cash Flow | 0.00 | 32.61B | 32.73B | 9.26B | 20.36B | 2.87B |
| Investing Cash Flow | 0.00 | -9.12B | -15.10B | -15.54B | -9.32B | -7.84B |
| Financing Cash Flow | 0.00 | -16.52B | -23.02B | 10.56B | -13.91B | 10.46B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | ¥487.62B | 9.25 | ― | 1.46% | 7.47% | 69.30% | |
84 Outperform | ¥410.89B | 6.79 | 8.36% | 2.71% | 2.14% | 111.05% | |
75 Outperform | ¥436.44B | 7.53 | 9.36% | 3.61% | 5.27% | -2.42% | |
74 Outperform | ¥145.64B | 10.91 | ― | 2.93% | 4.01% | 218.74% | |
68 Neutral | ¥580.74B | 28.26 | ― | 3.52% | 7.58% | 162.60% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
45 Neutral | ¥525.14B | -1.55 | 1.29% | 2.88% | -2.07% | -762.80% |